These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Managing therapy-associated neurotoxicity in children with ALL. Bhojwani D; Bansal R; Wayne AS Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):376-383. PubMed ID: 34889354 [TBL] [Abstract][Full Text] [Related]
14. New-Onset Refractory Status Epilepticus Associated With the Use of Synthetic Cannabinoids. Patel NA; Jerry JM; Jimenez XF; Hantus ST Psychosomatics; 2017; 58(2):180-186. PubMed ID: 28366218 [No Abstract] [Full Text] [Related]
18. CAR-T Cell Therapy-Related Neurotoxicity in Pediatric Acute Lymphoblastic Leukemia: Spectrum of Imaging Findings. Tan AP Pediatr Neurol; 2020 Oct; 111():51-58. PubMed ID: 32951662 [TBL] [Abstract][Full Text] [Related]
19. Imaging-based Toxicity and Response Pattern Assessment Following CAR T-Cell Therapy. Smith DA; Kikano E; Tirumani SH; de Lima M; Caimi P; Ramaiya NH Radiology; 2022 Feb; 302(2):438-445. PubMed ID: 34751616 [TBL] [Abstract][Full Text] [Related]